期刊文献+

胃癌血清和组织中Her-2/neu、MMP-2和Leptin的表达情况及临床意义 被引量:10

Expression and clinical significance of Her-2/neu,MMP-2 and Leptin in serum and tumor tissue of gastric carcinoma
下载PDF
导出
摘要 目的检测Her-2/neu、基质金属蛋白酶-2(MMP-2)和瘦素(Leptin)在胃癌血清和组织中表达情况,探讨它们在胃癌发生、发展过程中的作用。方法分别应用ELISA和免疫组化(IHC)法检测胃癌血清和组织中Her-2/neu、MMP-2和Leptin表达情况。结果 Her-2/neu、MMP-2、Leptin在胃癌血清中阳性表达率明显高于在正常对照组中阳性表达率(P<0.05);Her-2/neu、MMP-2、Leptin在胃癌组织中阳性表达率明显高于在癌旁组织中阳性表达率(P<0.05)。Her-2/neu、MMP-2、Leptin在胃癌血清和癌组织中阳性表达率具有一致性。Her-2/neu、MMP-2和Leptin在胃癌组织中的阳性表达均与浸润深度、淋巴结转移和TNM分期显著相关(P<0.05),与患者的性别、年龄、肿瘤大小、肿瘤部位和肿瘤分化程度均无相关性。Her-2/neu在血清中表达与浸润深度、淋巴结转移和TNM分期呈显著正相关(P<0.05);MMP-2在血清中表达与淋巴结转移呈正相关(P<0.05);Leptin在血清中表达与病理特征无明显相关性。结论 Her-2/neu、MMP-2和Leptin在胃癌的发生、发展和转移过程中起促进作用,针对Her-2/neu、MMP-2和Leptin的检测可用于临床诊断,指导靶向治疗,并为临床预后提供科学合理参考。 Objective Detected Her-2/neu, matrix metalloproteinases-2 (MMP-2) and Leptin in stomach cancer serum and tissue, discussed their roles in occurance and development of gastric cancer. Methods Detected the ex- pression of Her-2/neu, MMP-2 and Leptin in serum by ELISA, and detected the expression of Her-2/neu, MMP- 2 and Leptin in stomach cancer tissue by IHC. Results The positive rates of Her-2/neu, MMP-2, Leptin in gastric cancer serum were higher than the positive rates in control group ( P 〈 0. 05 ). The positive rates of Her-2/ neu, MMP-2, Leptin in gastric cancer tissues were higher than the positive rates in adjacent tissues (P 〈 0. 05 ). The positive expressions of two tests had consistency. In tissues, the positive expression rates of Her-2/neu, MMP-2 and Leptin were correlated with the depth of invasion,lymph node metastasis, clinical stage ( P 〈 0. 05 ). Their expression was not correlated with sex, age, size, site of tumor and the degree of differentiation. In serum, the positive expression of Her-2/neu was correlated with the depth of invasion, lymph node metastasis, clinical stage (P 〈 0. 05 ). The positive expression of MMP-2 was correlated with lymph node metastasis (P 〈 0. 05 ). The positive expression of Leptin had no significant correlation with pathological features. Conclusion Her-2/neu, MMP-2 and Leptin promote the occurrence, development and transfer process of gastric cancer. It can be used for clinical diagnosis, guide the targeted therapy and provide scientific and reasonable reference for gastric cancer prognosis.
作者 葛尔树 刘弋
出处 《安徽医科大学学报》 CAS 北大核心 2014年第1期76-80,共5页 Acta Universitatis Medicinalis Anhui
基金 安徽省临床医学重点学科应用技术计划(编号:05A036)
关键词 胃肿瘤 HER-2 NEU 基质金属蛋白酶-2 瘦素 gastric carcinoma Her-2/neu MMP-2 Leptin
  • 相关文献

参考文献9

  • 1Semba K, Kamata N, Toyoshima K, et al. A V-erbB-related roton- cogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland ade- nocarcinomn [ J ]. Proc Natl Acud Sci USA, 1985,82 ( 19 ) :6497 - 501.
  • 2Lordick F, Leong-Chong J, Kang Y, et al. Her2 status of advanced gastric cancer is similar in Europe and Asia[J]. Ann Oncol,2007, 18 ( Suppl 7 ) :253.
  • 3Hang X L,Yang Y S,Xu D P,et al. Comparative study on overex-pression of HER2/neu and HER3 in gastric cancer [ J ]. World J Surg ,2009,33 (10) :2112 - 8.
  • 4吴倩,张红,张和平.组织芯片技术研究CD147和MMP-2在胃癌中的表达[J].安徽医科大学学报,2010,45(1):43-46. 被引量:12
  • 5陈美芳,季峰,厉有名.食管癌基质金属蛋白酶及其组织抑制剂表达的研究[J].中华消化杂志,2002,22(3):181-183. 被引量:15
  • 6Monig S P, Baldus S E, Hennecken J K, et al. Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma[J]. Histopathology, 2001,39(6) :597 -602.
  • 7Ke Z, Lin H, Fan Z, et al. MMP-2 mediates ethanol-induced inva- sion of mammary epithelial cells Cancer,2006,119 ( 1 ) :8 - 16.
  • 8Surmaez E, Fiorio E, Mercanti A. Leptin/HER-2 crosstalk in breast cancer:in vitro study and preliminary in vivo analysis [ J ]. BMC Cancer,2008,8:305.
  • 9Van Hul M, Lijnen H R. Matrix metalloproteinase inhibition im- pairs murine adipose tissue development independently of leptin [J]. Endoer J,2011,58 (2) :101 -7.

二级参考文献16

  • 1Sun J, Hemler M E. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions [ J ]. Cancer Res,2001,61 (5) : 2276 - 81.
  • 2Jiang Y, Goldberg I D, Shi Y E. Complex roles of tissue inhibitors of metalloproteinases in cancer [ J ]. Oncogene, 2002,21 ( 14 ) : 2245 - 52.
  • 3Shah F D, Shukla S N, Shah P M, et al. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer [ J ]. Indian J Cancer,2009,46 ( 3 ), 194 - 202.
  • 4Biswas C,Zhang Y, DeCastro R, et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN ) is a member of the immunoglobulin superfamily[ J]. Cancer Res, 1995, 55(2) : 434 -9.
  • 5Riethdorf S, Reimers N, Assmann V, et al. High incidence of EMMPRIN expression in human tumors [ J ]. Int J Cancer,2006, 119(8) :1800 - 10.
  • 6Nabeshima K, Iwasaki H, Koga K, et al. Emmprin ( basigin/ CD147 ) : matrix metalloproteinase modulator and multifunetional cell recognition molecule that plays a critical role in cancer progression[ J]. Pathol Int,2006,56(7 ) :359 -67.
  • 7Michele C, Madigan, Elizabeth A, et aL The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression [ J ]. Cancer Immunol Immunother,2008,57 (9) : 1367 - 79.
  • 8Zheng H C, Takahashl H, Mural Y, et al. Upregulated EMMPRIN/ CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good markerm for local invasion and prognosis[ J]. British J Cancer,2006,95 (10) : 1371 - 8.
  • 9Murray GI,Duncan ME,O'Neil P,et al.Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.J Pathol,1998,185:256-261.
  • 10Imai K,Yokohama Y,Nakanishi I,et al.Matrix metalloproteinases 7(matrilysin) from human rectal carcinoma cell.Activation of the precursor,interaction with other matrix metalloproteinases and enzymic properties.J Biol Chem,1995,270:6691-6697.

共引文献24

同被引文献103

引证文献10

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部